January 9, 2018 / 5:00 PM / Updated 15 minutes ago BRIEF-Amgen Expects To Launch Migraine Drug This Year Reuters Staff 
Jan 9 (Reuters) - Amgen Inc: 
* AMGEN CEO SAYS EXPECTS TO BE ABLE TO LAUNCH AIMOVIG FOR MIGRAINE THIS YEAR 
* AMGEN SAYS EXPECTS TO LAUNCH HUMIRA BIOSIMILAR OUTSIDE U.S. THIS YEAR 
* AMGEN CEO SAYS BUSINESS DEVELOPMENT DEALS TO REMAIN PRIORITY IN 2018 
* AMGEN CEO SAYS COMPANY IN STRONGER STRATEGIC POSITION AFTER TAX REFORM Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)